Myriad Genetics, Inc. revenue breakdown overview

Myriad Genetics, Inc. revenue for the last year amounted to 753.20 M USD, the most of which — 327.80 M USD — came from its highest performing source at the moment, Hereditary Cancers, the year earlier bringing 305.50 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Myriad Genetics, Inc. 671.70 M USD, and the year before that — 591.50 M USD.